Showing 1 - 11 results of 11 for search 'Ann W. Silk', query time: 0.05s
Refine Results
-
1
-
2
A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma by Ann W. Silk, Ann W. Silk, Ann W. Silk, Ann W. Silk, Brendan Curti, Jennifer Bryan, Jennifer Bryan, Tracie Saunders, Weichung Shih, Michael P. Kane, Phoebe Hannon, Christopher Fountain, Jessica Felcher, Andrew Zloza, Andrew Zloza, Andrew Zloza, Howard L. Kaufman, Howard L. Kaufman, Howard L. Kaufman, Howard L. Kaufman, Howard L. Kaufman, Janice M. Mehnert, Janice M. Mehnert, Janice M. Mehnert, David F. McDermott, David F. McDermott
Published 2023-02-01
Article -
3
High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma by Ann W. Silk, Ann W. Silk, Howard L. Kaufman, Howard L. Kaufman, Howard L. Kaufman, Brendan Curti, Janice M. Mehnert, Kim Margolin, David McDermott, Joseph Clark, Jenna Newman, Praveen K. Bommareddy, Praveen K. Bommareddy, Lisa Denzin, Lisa Denzin, Lisa Denzin, Saltanat Najmi, Saltanat Najmi, Azra Haider, Azra Haider, Weichung Shih, Michael P. Kane, Andrew Zloza, Andrew Zloza
Published 2020-01-01
Article -
4
Outcomes of palliative radiation therapy for cutaneous squamous cell carcinoma: A retrospective cohort study by Emily Y. Kim, BS, Emily E. Granger, BS, Jonathan D. Schoenfeld, MD, MPH, Ann W. Silk, MD, Danielle Margalit, MD, MPH, Roy Tishler, MD, PhD, Emily S. Ruiz, MD, MPH
Published 2024-03-01
Article -
5
A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors by Ann W. Silk, Biren Saraiya, Roman Groisberg, Nancy Chan, Kristen Spencer, Eugenia Girda, Weichung Shih, Marisa Palmeri, Tracie Saunders, Robert M. Berman, Vlad Coric, Suzie Chen, Andrew Zloza, Joshua Vieth, Janice M. Mehnert, Jyoti Malhotra
Published 2022-07-01
Article -
6
Leptomeningeal carcinomatosis from a recurrent cutaneous squamous cell carcinoma with perineural invasion in a lung transplant patient by Emily E. Granger, BS, Ann W. Silk, MD, Nirmal S. Sharma, MD, Morgan K. Groover, BS, Jeffrey P. Guenette, MD, Kevin S. Emerick, MD, David M. Miller, MD, PhD, Katherine A. Krause, MD, Emily S. Ruiz, MD, MPH
Published 2023-07-01
Article -
7
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer by Christopher A Barker, Evan J Lipson, Harriet Kluger, Brian R Gastman, Michael T Tetzlaff, Igor Puzanov, Shailender Bhatia, Paul Nghiem, Ann W Silk, Zeynep Eroglu, Sunandana Chandra, Isaac Brownell, Anna C Pavlick, David M Miller, Vernon K Sondak, Kari L Kendra, Kathryn B Bollin, Kathleen Madden, Guilherme Rabinowits, Emily S Ruiz, Edward A Tavss
Published 2022-07-01
Article -
8
A multicenter real-world analysis of first-line systemic monotherapy for locally advanced basal cell carcinoma by Morgan K. Groover, BS, Neha Gupta, MD, MPH, Emily Granger, BS, Fadi Murad, MD, MPH, Vernon J. Forrester, MD, Emily J. Anstadt, MD, PhD, William Su, MD, Lauren Heusinkveld, MD, John N. Lukens, MD, Ann W. Silk, MD, MS, Allison T. Vidimos, RPh, MD, Jonathan D. Schoenfeld, MD, MPH, Shlomo A. Koyfman, MD, Emily S. Ruiz, MD, MPH
Published 2023-12-01
Article -
9
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer by Sharad Goyal, Howard L Kaufman, Andrew Zloza, Ann W Silk, Vineet Gupta, Shang-Jui Wang, Bruce G Haffty, Nicole R LeBoeuf, Sachin R Jhawar, Jose A Guevara-Patino, Timothy M Kuzel, Jochen Reiser, Aditya Thandoni, Praveen K Bommareddy, Jenna H Newman, Amanda L Marzo, Preston Daniels, Devora Schiff, Darrion Mitchell, Christopher Simmons, Ahmed Lasfar, Eileena F Giurini
Published 2023-07-01
Article -
10
Clinical characterization of colitis arising from anti-PD-1 based therapy by Daniel Y Wang, Meghan J Mooradian, DaeWon Kim, Neil J Shah, Sarah E Fenton, Robert M Conry, Rutika Mehta, Ann W. Silk, Alice Zhou, Margaret L Compton, Rami N Al-Rohil, Sunyoung Lee, Amber L Voorhees, Lisa Ha, Svetlana McKee, Jacqueline T Norrell, Janice Mehnert, Igor Puzanov, Jeffrey A Sosman, Sunandana Chandra, Geoffrey T Gibney, Suthee Rapisuwon, Zeynep Eroglu, Ryan Sullivan, Douglas B Johnson
Published 2019-01-01
Article -
11
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration by Mark N. Stein, Jyoti Malhotra, Rohinton S. Tarapore, Usha Malhotra, Ann W. Silk, Nancy Chan, Lorna Rodriguez, Joseph Aisner, Robert D. Aiken, Tina Mayer, Bruce G. Haffty, Jenna H. Newman, Salvatore M. Aspromonte, Praveen K. Bommareddy, Ricardo Estupinian, Charles B. Chesson, Evita T. Sadimin, Shengguo Li, Daniel J. Medina, Tracie Saunders, Melissa Frankel, Aparna Kareddula, Sherrie Damare, Elayne Wesolowsky, Christian Gabel, Wafik S. El-Deiry, Varun V. Prabhu, Joshua E. Allen, Martin Stogniew, Wolfgang Oster, Joseph R. Bertino, Steven K. Libutti, Janice M. Mehnert, Andrew Zloza
Published 2019-05-01
Article